Is NUVB stock safe? | Glauxie AI

Q: Is NUVB stock safe?

Nuvation Bio Inc. (NUVB) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO David T. Hung. Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule... Employees: 1,000,000.

Q: What are the risks of investing in NUVB?

Identify key risks of investing in NUVB — debt, competition, volatility, and sector headwinds.

Q: Is NUVB a good long-term investment?

Evaluate NUVB as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does NUVB have?

Review NUVB total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is NUVB stock safe?

🦉

Nuvation Bio Inc. (NUVB)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODavid T. Hung

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a...

Key Executives

Name	Title
Colleen Sjogren	Chief Commercial Officer
David C. Hanley	Chief Technical Operations Officer
David Liu	Chief Medical Officer
David T. Hung	Founder, President, Chief Executive Officer & Chairman
Gary Hattersley	Chief Scientific Officer
Kerry A. Wentworth	Chief Regulatory Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

NUVB Profile Financials

What are the risks of investing in NUVB? Is NUVB a good long-term investment? How much debt does NUVB have?